Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 2
2010 4
2011 1
2012 1
2013 2
2015 1
2016 4
2017 3
2018 4
2019 8
2020 8
2021 7
2022 6
2023 2
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

46 results

Results by year

Filters applied: . Clear all
Page 1
Olaparib plus Durvalumab, with or without Bevacizumab, as Treatment in PARP Inhibitor-Naïve Platinum-Sensitive Relapsed Ovarian Cancer: A Phase II Multi-Cohort Study.
Drew Y, Kim JW, Penson RT, O'Malley DM, Parkinson C, Roxburgh P, Plummer R, Im SA, Imbimbo M, Ferguson M, Rosengarten O, Steeghs N, Kim MH, Gal-Yam E, Tsoref D, Kim JH, You B, De Jonge M, Lalisang R, Gort E, Bastian S, Meyer K, Feeney L, Baker N, Ah-See ML, Domchek SM, Banerjee S; MEDIOLA Investigators. Drew Y, et al. Clin Cancer Res. 2024 Jan 5;30(1):50-62. doi: 10.1158/1078-0432.CCR-23-2249. Clin Cancer Res. 2024. PMID: 37939124 Free PMC article. Clinical Trial.
Tisotumab Vedotin in Previously Treated Recurrent or Metastatic Cervical Cancer.
Hong DS, Concin N, Vergote I, de Bono JS, Slomovitz BM, Drew Y, Arkenau HT, Machiels JP, Spicer JF, Jones R, Forster MD, Cornez N, Gennigens C, Johnson ML, Thistlethwaite FC, Rangwala RA, Ghatta S, Windfeld K, Harris JR, Lassen UN, Coleman RL. Hong DS, et al. Among authors: drew y. Clin Cancer Res. 2020 Mar 15;26(6):1220-1228. doi: 10.1158/1078-0432.CCR-19-2962. Epub 2019 Dec 3. Clin Cancer Res. 2020. PMID: 31796521 Clinical Trial.
Homologous recombination deficiency and ovarian cancer.
Ledermann JA, Drew Y, Kristeleit RS. Ledermann JA, et al. Among authors: drew y. Eur J Cancer. 2016 Jun;60:49-58. doi: 10.1016/j.ejca.2016.03.005. Epub 2016 Apr 9. Eur J Cancer. 2016. PMID: 27065456 Review.
Targeting the ATR-CHK1 Axis in Cancer Therapy.
Rundle S, Bradbury A, Drew Y, Curtin NJ. Rundle S, et al. Among authors: drew y. Cancers (Basel). 2017 Apr 27;9(5):41. doi: 10.3390/cancers9050041. Cancers (Basel). 2017. PMID: 28448462 Free PMC article. Review.
Emerging treatment options for ovarian cancer: focus on rucaparib.
Mariappan L, Jiang XY, Jackson J, Drew Y. Mariappan L, et al. Among authors: drew y. Int J Womens Health. 2017 Dec 15;9:913-924. doi: 10.2147/IJWH.S151194. eCollection 2017. Int J Womens Health. 2017. PMID: 29290694 Free PMC article. Review.
Academic opportunities within clinical oncology training.
Goranov BB, Drew Y, Graham J, Iqbal MS, Kagzi M, Mahtab N, Pearson R, Smith E, Mulvenna P. Goranov BB, et al. Among authors: drew y. Clin Oncol (R Coll Radiol). 2013 Jul;25(7):446. doi: 10.1016/j.clon.2013.03.004. Epub 2013 Apr 11. Clin Oncol (R Coll Radiol). 2013. PMID: 23582955 No abstract available.
British Gynaecological Cancer Society (BGCS) uterine cancer guidelines: Recommendations for practice.
Morrison J, Balega J, Buckley L, Clamp A, Crosbie E, Drew Y, Durrant L, Forrest J, Fotopoulou C, Gajjar K, Ganesan R, Gupta J, Hughes J, Miles T, Moss E, Nanthakumar M, Newton C, Ryan N, Walther A, Taylor A. Morrison J, et al. Among authors: drew y. Eur J Obstet Gynecol Reprod Biol. 2022 Mar;270:50-89. doi: 10.1016/j.ejogrb.2021.11.423. Epub 2021 Nov 25. Eur J Obstet Gynecol Reprod Biol. 2022. PMID: 35065448 No abstract available.
46 results